NCT05239169 2025-05-01
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Tianjin Medical University Cancer Institute and Hospital
University of California, San Francisco
Azienda Ospedaliera di Padova